Related Experiment Video

Updated: Aug 16, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

Unique features of inflammatory breast carcinoma

Xavier Bosch

    The Lancet. Oncology
    |August 13, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
    07:05

    Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

    Published on: January 20, 2019

    Related Experiment Videos

    Last Updated: Aug 16, 2026

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
    05:02

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

    Published on: February 4, 2021

    Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
    07:05

    Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

    Published on: January 20, 2019

    Related Concept Videos

    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

    Articles linked to this work by shared authors, journal, and citation graph.

    Symptomatic presentation of cancer in patients diagnosed following emergency self-referral and prior general practice consultations.

    Postgraduate medicine·2026

    Missed opportunities for earlier cancer diagnosis within specific pathways to emergency presentation.

    Future oncology (London, England)·2025

    Patients' perceptions on reasons for self-referring to the emergency department shortly before a cancer diagnosis: a qualitative study.

    The British journal of general practice : the journal of the Royal College of General Practitioners·2025

    Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome.

    International journal of cancer·2025

    Clinical characterisation of patients diagnosed with cancer following emergency self-referral.

    Cancer epidemiology·2024

    Time to Diagnosis and Presenting Symptoms of Patients Diagnosed With Cancer Through Emergency and Nonemergency Routes: A Large Retrospective Study From a High-Volume Center.

    JCO oncology practice·2024

    Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

    The Lancet. Oncology·2026

    Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

    The Lancet. Oncology·2026

    Advancing oncology education in low-income and middle-income African settings: global insights for local action.

    The Lancet. Oncology·2026

    Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

    The Lancet. Oncology·2026

    Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

    The Lancet. Oncology·2026

    Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

    The Lancet. Oncology·2026

    Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

    Frontiers in oncology·2026

    Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

    Nature reviews. Cancer·2026

    Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

    Clinical rheumatology·2026

    Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

    JTO clinical and research reports·2026

    Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

    Cancer research·2026

    Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

    Frontiers in microbiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us